Cited by 33Asthma and respiratory diseasesOccupational exposure and asthmaChronic Obstructive Pulmonary Disease (COPD) Research

Severe asthma: looking beyond the amount of medication

Open access
Bush, Andrew, Saglani, Sejal, Fleming, Louise·2017·The Lancet Respiratory Medicine

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(17)30379-x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • When severe asthma was defined using ERS/ATS or WHO criteria, only a small number of children were classified as having severe asthma, suggesting that we need to look beyond the amount of medication and disease control when defining severe disease.

    “However, when “severe asthma” was defined using ERS/ATS (35) or WHO (41) criteria, only a small number of children were classified as having severe asthma, suggesting that we need to look beyond the amount of medication and disease control when defining severe disease (46).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [46]

  • The limitation of the use of maximum treatment is that there may be different reasons for poor asthma control among patients on maximum treatment, such as wrong diagnosis, non-adherence with medication, or therapy-resistant disease.

    “The limitation of the use of “maximum treatment” is that there may be different reasons for poor asthma control among patients on “maximum treatment,” such as the wrong diagnosis (46), non-adherence with medication (50), or therapy-resistant disease (48).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [46]

  • Despite interventions and treatments aimed at addressing modifiable factors and comorbidities, some children with difficult asthma and Asthma plus may not improve because of continued poor adherence with medications or ongoing high exposure to allergens, in which case they should be considered as having refractory difficult asthma or refractory Asthma plus.

    “However, despite interventions and treatments aimed at addressing modifiable factors and comorbidities, some children with DA and Asthma plus may not improve [e.g., because of the continued poor adherence with medications (50, 68), or ongoing high exposure to allergens (69–71)], in which case they should be considered as having refractory DA or refractory Asthma plus (46, 72).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [46]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bush, A., Saglani, S., & Fleming, L.
Affiliations
Royal Brompton Hospital (GB)
Corresponding author
Bush, Andrew
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2017-11
Volume
5
Issue
11
Pages
844-846
ISSN
2213-2600 (ISSN-L)
OpenAlex
W2762883190
Cited by
33
References
15
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 8 · 2020: 2 · 2019: 13 · 2018: 1 · 2017: 1
FWCI
3.45
Type
journal article
Language
en
Open access
Locations
  • The Lancet Respiratory Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
National Institute for Health and Care Research (CDF-2014-07-019)
Topics
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
severe asthma, childhood asthma, difficult-to-treat asthma, therapy-resistant asthma, asthma comorbidity, bronchoscopy, airway pathology, biologic therapy, precision medicine, eosinophilia, airway remodeling, Th2 cytokines, asthma phenotyping, specialist referral, asthma action plan
MeSH terms
Asthma, Child, Humans, Severity of Illness Index, Treatment Failure, Anti-Asthmatic Agents, Practice Patterns, Nurses', Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review